Trial intelligence / Profile preview

Arteriosclerosis and Systemic Lupus Erythematosus: Can Statins Stop This Process?

2008-005147-42Phase 4Active

Sponsor
Mª Angeles Aguirre Zamorano
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of fluvastatin in systemic lupus erythematosus (SLE) and atherosclerosis, sponsored by Mª Angeles Aguirre Zamorano. Primary endpoint: Delay in carotid intima-media thickness increase. Started Sep 2008; status: active.

02

Drugs

fluvastatin
03

Conditions

systemic lupus erythematosus (SLE)atherosclerosis

Beyond the preview

Go deeper on 2008-005147-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005147-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call